Tara L. Kieffer, Ph.D.
Affiliations: | 2005 | Johns Hopkins University, Baltimore, MD |
Area:
Molecular Biology, ImmunologyGoogle:
"Tara Kieffer"Parents
Sign in to add mentor| Robert F. Siliciano | grad student | 2005 | Johns Hopkins | |
| (Mechanisms of HIV-1 persistence in the presence of highly active antiretroviral therapy (HAART).) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kieffer TL, George S. (2014) Resistance to hepatitis C virus protease inhibitors. Current Opinion in Virology. 8: 16-21 |
| Jiang M, Mani N, Lin C, et al. (2013) In vitro phenotypic characterization of hepatitis C virus NS3 protease variants observed in clinical studies of telaprevir. Antimicrobial Agents and Chemotherapy. 57: 6236-45 |
| Adda N, Bartels DJ, Gritz L, et al. (2013) Futility rules for telaprevir combination treatment for patients with hepatitis C virus infection. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 11: 193-5 |
| Bartels DJ, Sullivan JC, Zhang EZ, et al. (2013) Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment. Journal of Virology. 87: 1544-53 |
| Thomas XV, de Bruijne J, Sullivan JC, et al. (2012) Evaluation of persistence of resistant variants with ultra-deep pyrosequencing in chronic hepatitis C patients treated with telaprevir. Plos One. 7: e41191 |
| Kieffer TL, Sarrazin C, Miller JS, et al. (2007) Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients. Hepatology (Baltimore, Md.). 46: 631-9 |
| Nettles RE, Kieffer TL. (2006) Update on HIV-1 viral load blips. Current Opinion in Hiv and Aids. 1: 157-61 |
| Bailey JR, Sedaghat AR, Kieffer T, et al. (2006) Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells. Journal of Virology. 80: 6441-57 |
| Nettles RE, Kieffer TL, Parsons T, et al. (2006) Marked intraindividual variability in antiretroviral concentrations may limit the utility of therapeutic drug monitoring. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 1189-96 |
| Lee PK, Kieffer TL, Siliciano RF, et al. (2006) HIV-1 viral load blips are of limited clinical significance. The Journal of Antimicrobial Chemotherapy. 57: 803-5 |